Hanson & Doremus Investment Management Moderna, Inc. Transaction History

Hanson & Doremus Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$117.13 - $176.59 $2,693 - $4,061	23 New	23 $3,000
Q1 2022 Apr 22, 2022	SELL	$126.46 - $235.05 $1,643 - $3,055	-13 Closed	0 $0
Q3 2021 Oct 21, 2021	SELL	$221.9 - $484.47 $14,867 - $32,459	-67 Reduced 83.75%	13 $5,000
Q2 2021 Jul 22, 2021	BUY	$129.91 - $234.98 $8,703 - $15,743	67 Added 515.38%	80 $6,000
Q1 2021 May 03, 2021	BUY	$109.18 - $185.98 $1,419 - $2,417	13 New	13 $2,000
Q4 2020 Feb 01, 2021	SELL	$65.74 - $169.86 $5,259 - $13,588	-80 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$54.34 - $94.85 $2,988 - $5,216	55 Added 220.0%	80 $6,000
Q2 2020 Jul 17, 2020	BUY	$29.67 - $80.0 $741 - $2,000	25 New	25 $2,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

Stay updated on Hanson & Doremus Investment Management with notifications on news.